...
首页> 外文期刊>World neurosurgery >Hypoxia-Inducible Factor 1α and AT-Rich Interactive Domain-Containing Protein 1A Expression in Pituitary Adenomas: Association with Pathological, Clinical, and Radiological Features
【24h】

Hypoxia-Inducible Factor 1α and AT-Rich Interactive Domain-Containing Protein 1A Expression in Pituitary Adenomas: Association with Pathological, Clinical, and Radiological Features

机译:缺氧诱导因子1α和含有富含含有的含有域的含有域的蛋白质1A表达在垂体腺瘤中:与病理,临床和放射性特征相关联

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BackgroundHypoxia-inducible factor (HIF) plays a major role in tumorigenesis and cancer progression. In hypoxic conditions, HIF is upregulated and has been shown to activate multiple genes required for cells to adapt to hypoxia. AT-rich interactive domain-containing protein 1A (ARID1A), a SWI/SNF (switch/sucrose nonfermentable) chromatin remodeling gene has context-dependent tumor-suppressive and oncogenic roles in cancer. We assessed the correlations between the expression and mutations of HIF1A and ARID1A in histopathologically confirmed pituitary adenomas. MethodsWe performed a retrospective analysis of 71 patients who had undergone surgery for pituitary adenoma. Patient demographic, radiological, and histopathological features were correlated with HIF1A and ARID1A expression. ResultsMost cases were HIF1A positive (62%). No significant correlation was found between HIF1A expression and age, gender, tumor size, bone erosion, hemorrhage, or Ki-67 index. An inverse correlation was demonstrated between HIF1A and cavernous sinus invasion (P?= 0.035). ARID1A loss was found in 28.2% of pituitary adenomas. No significant correlation was found between ARID1A and any of the assessed variables. ConclusionsIn our patient cohort, we found that most pituitary adenomas expressed HIF1A. To the best of our knowledge, we are the first to assess the presence of ARID1A loss in pituitary adenomas, which occurred in 28.2% of cases. No individual demographic, imaging, or histopathological feature was predictive of ARID1A. Likewise, with the exception of an increased incidence of cavernous sinus invasion, no correlation was found with HIF1A. Given the prognostic value of these markers in other malignancies, their frequency in pituitary adenomas warrants further exploration of their potential role in pituitary adenoma treatment and outcome.
机译:背景氧氧ia-诱导因子(HIF)在肿瘤发生和癌症进展中起主要作用。在缺氧条件下,上调HIF,已被证明激活细胞所需的多种基因以适应缺氧。含有富含含有含有域的蛋白质1A(ARID1A),SWI / SNF(开关/蔗糖非功能性)染色质重塑基因具有癌症中的依赖性肿瘤抑制和致癌作用。我们评估了HIF1A和ARID1A在组织病理学证实垂体腺瘤中的表达和突变之间的相关性。方法对71名患者进行了对垂体腺瘤进行手术的回顾性分析。患者人口统计学,放射性和组织病理学特征与HIF1A和ARID1A表达相关。结果是HIF1A阳性(62%)。 HIF1A表达和年龄,性别,肿瘤大小,骨腐蚀,出血或KI-67指数没有显着相关性。 HIF1a和海绵窦侵袭之间证明了反比异性(p?= 0.035)。 ARID1A损失在28.2%的垂体腺瘤中发现。在ARID1A和任何评估变量之间没有发现显着的相关性。结论我们的患者队列,我们​​发现大多数垂体腺瘤表达了HIF1A。据我们所知,我们是第一个评估垂体腺瘤中ARID1A损失的存在,其中28.2%的病例发生。没有个体人口统计学,成像或组织病理学特征是对ARID1A的预测性的。同样,除了增加海绵窦侵袭的发生率,HIF1a没有发现相关性。鉴于这些标志物在其他恶性肿瘤中的预后价值,它们在垂体腺瘤中的频率令他们进一步探讨其在垂体腺瘤治疗和结果中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号